Soligenix Stock (NASDAQ:SNGX), Trade Ideas

Soligenix

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Soligenix Inc

<h3>Gainers</h3>
<ul>
<li>Mobile-health Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDR#NASDAQ">MNDR</a>) shares rose 15.0% to $31.35 during Friday's after-market session. The company's market cap stands at $1.0 billion. </li>
<li>Galera Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRTX#NASDAQ">GRTX</a>) stock increased by 9.13% to $0.2. The market value of their outstanding shares is at $10.9 million. </li>
<li>Innovative Eyewear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCY#NASDAQ">LUCY</a>) shares increased by 8.54% to $0.26. The company's market cap stands at $3.4 million. </li>
<li>China Pharma Holdings, Inc. Common Stock (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CPHI#AMEX">CPHI</a>) stock moved upwards by 6.7% to $0.34. </li>
<li>Calidi Biotherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) shares increased by 6.17% to $0.17. The market value of their outstanding shares is at $8.4 million. </li>
<li>Adaptimmune Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADAP#NASDAQ">ADAP</a>) shares increased by 6.04% to $1.04. The company's market cap stands at $264.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Vaxxinity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VAXX#NASDAQ">VAXX</a>) shares decreased by 10.7% to $0.43 during Friday's after-market session. The company's market cap stands at $53.8 million. </li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) stock declined by 9.26% to $6.37. The market value of their outstanding shares is at $5.8 million. </li>
<li>Tiziana Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLSA#NASDAQ">TLSA</a>) shares decreased by 8.24% to $0.61. The company's market cap stands at $61.4 million. </li>
<li>Soligenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) shares decreased by 7.17% to $0.4. The market value of their outstanding shares is at $4.2 million. </li>
<li>Clene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNN#NASDAQ">CLNN</a>) stock decreased by 6.94% to $0.33. The company's market cap stands at $41.7 million. </li>
<li>Metagenomi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGX#NASDAQ">MGX</a>) stock fell 5.67% to $6.5. The market value of their outstanding shares is at $243.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ADAP

CLDI

CLNN

CPHI

GRTX

LUCY

MNDR

SNGX

TLSA

TTNP

VAXX

12 Health Care Stocks Moving In Friday's After-Market Session

Shares of Wang &amp; Lee Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) rose sharply in today's pre-market trading after the company reported a year-over-year <a href="https://www.benzinga.com/quote/WLGS/earnings">increase in FY23 financial results</a>.
Wang &amp; Lee Group posted a FY23 loss of 2 cents per share, versus a year-ago loss of 5 cents per share. The company's revenue came in at $6.83 million versus, $4.17 million in the year-ago period, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Wang &amp; Lee Group shares jumped 37.7% to $0.7220 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading" id="h-gainers">Gainers</h3>
<ul>
<li>Redwoods Acquisition Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RWOD#NASDAQ">RWOD</a>) shares gained 141% to $17.83 in pre-market trading after falling around 3% on Thursday.</li>
<li>Zhongchao Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCMD#NASDAQ">ZCMD</a>) gained 75.6% to $2.53 in pre-market trading after gaining over 7% on Thursday.</li>
<li>Trio Petroleum Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPET#NYSE">TPET</a>) gained 30% to $0.4261 in pre-market trading. The company on Wednesday announced it entered into a securities purchase agreement with an institutional investor in the amount of $360,000.</li>
<li>HUB Cyber Security Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUBC#NASDAQ">HUBC</a>) shares rose 24.7% to $1.61 in pre-market trading after falling 4% on Thursday.</li>
<li>SuperCom Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPCB#NASDAQ">SPCB</a>) gained 22% to $0.2927 in pre-market trading. SuperCom shares fell around 33% on Thursday after the company priced a $2.9 million registered direct offering.</li>
<li>Bio-Path Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTH#NASDAQ">BPTH</a>) rose 19.3% to $5.01 in today's pre-market trading after jumping 30% on Thursday. Bio-Path announced a $1.2 million registered direct offering priced at-the-market under Nasdaq rules.</li>
<li>Centogene N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTG#NASDAQ">CNTG</a>) shares gained 19.3% to $0.5513 in pre-market trading.</li>
<li>Kineta, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KA#NASDAQ">KA</a>) rose 14.7% to $0.5601 in pre-market trading. Kineta was recently granted a US patent titled &#8216;Proteasome activity enhancing compounds (including methods for treating cancer or tumors).&#8217;</li>
<li>Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>) shares gained 10.5% to $12.12 in pre-market trading. Apollo Global Management and Sony Group Corp. are reportedly in talks on a joint offer for Paramount Global.</li>
</ul>
<h3 class="wp-block-heading" id="h-losers">Losers</h3>
<ul>
<li>BioNexus Gene Lab Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGLC#NASDAQ">BGLC</a>) fell 22.4% to $0.66 in pre-market trading after jumping around 29% on Thursday. BioNexus Gene Lab agreed to invest RM 1.2 million in Ascension Innovation (AISB) to advance digital health innovation through AI adoption in healthcare.</li>
<li>Tian Ruixiang Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIRX#NASDAQ">TIRX</a>) fell 19.9% to $0.6407 in pre-market trading after surging 65% on Thursday.</li>
<li>iSpecimen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPC#NASDAQ">ISPC</a>) fell 19.3% to $0.3396 in pre-market trading after gaining around 98% on Thursday.</li>
<li>AGBA Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGBA#NASDAQ">AGBA</a>) fell 13.6% to $0.89 in pre-market trading. AGBA Group Holding shares jumped 155% on Thursday higher after the company announced it entered into a definitive merger agreement with Triller.</li>
<li>Spectaire Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPEC#NASDAQ">SPEC</a>) declined 12.3% to $0.5426 in pre-market trading after falling over 20% on Thursday. Spectaire Holdings recently signed a distribution partnership agreement with a Fortune 1000 Energy Company.</li>
<li>Lantern Pharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRN#NASDAQ">LTRN</a>) shares fell 12.1% to $5.07 in pre-market trading.</li>
<li>Adaptive Biotechnologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADPT#NASDAQ">ADPT</a>) shares declined 11.4% to $2.07 in pre-market trading. Adaptive Biotechnologies is expected to report financial results for the first quarter 2024 after the closing bell on May 7, 2024.</li>
<li>Soligenix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) shares fell 11.1% to $0.3870 in pre-market trading. Soligenix shares fell around 15% on Thursday after the company announced the pricing of a $4.75 million public offering.</li>
<li>MicroCloud Hologram Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) fell 10.2% to $2.65 pre-market trading after jumping around 32% on Thursday.</li>
<li>Netflix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) fell 6% to $573.81 pre-market trading. Netflix reported upbeat earnings and sales results for its first quarter. The company added 9.33 million paid net new subscribers in the first quarter to bring the company to a total of 269.60 million.</li>
</ul>

Read More: <a href="https://www.benzinga.com/news/earnings/24/04/38329059/netflix-procter-gamble-and-3-stocks-to-watch-heading-into-friday">Netflix, Procter &amp; Gamble And 3 Stocks To Watch Heading Into Friday</a>

News

Pre-Market Outlook

Markets

ADPT

AGBA

BGLC

BPTH

CNTG

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

HUBC

ISPC

LTRN

NFLX

PARA

RWOD

SPCB

SPEC

TIRX

TPET

WLGS

ZCMD

Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket

WIIM

Soligenix shares are trading lower after the company announced the pricing of a $4.75 million public offering.

Offerings

Soligenix Announces Pricing Of $4.75M Public Offering Of 11,975,000 Shares And Warrants At $0.40/Share And Accompanying Warrant

<h3>Gainers</h3>
<ul>
<li>Bio-Path Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTH#NASDAQ">BPTH</a>) shares increased by 43.8% to $4.66 during Thursday's pre-market session. The market value of their outstanding shares is at $3.5 million. </li>
<li>SINTX Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SINT#NASDAQ">SINT</a>) shares moved upwards by 39.41% to $0.05. The company's market cap stands at $6.3 million. </li>
<li>23andMe Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ME#NASDAQ">ME</a>) stock moved upwards by 26.61% to $0.45. The company's market cap stands at $217.7 million. </li>
<li>Benitec Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTC#NASDAQ">BNTC</a>) shares rose 25.62% to $6.03. The company's market cap stands at $15.6 million. </li>
<li>Trevena (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVN#NASDAQ">TRVN</a>) stock moved upwards by 22.86% to $0.49. The company's market cap stands at $9.0 million. </li>
<li>Citius Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTXR#NASDAQ">CTXR</a>) stock moved upwards by 16.38% to $0.95. The company's market cap stands at $151.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>NRX Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRXP#NASDAQ">NRXP</a>) shares declined by 22.5% to $3.24 during Thursday's pre-market session. The company's market cap stands at $31.0 million. </li>
<li>Soligenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) stock decreased by 17.61% to $0.42. The market value of their outstanding shares is at $4.4 million. </li>
<li>Sonoma Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNOA#NASDAQ">SNOA</a>) stock declined by 13.75% to $0.14. The company's market cap stands at $2.2 million. </li>
<li>Mustang Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) shares fell 11.12% to $0.34. The company's market cap stands at $3.5 million. </li>
<li>Dynatronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYNT#NASDAQ">DYNT</a>) stock fell 10.26% to $0.53. The market value of their outstanding shares is at $2.5 million. </li>
<li>SeaStar Medical Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICU#NASDAQ">ICU</a>) shares decreased by 9.46% to $0.63. The company's market cap stands at $47.7 million. As per the press release, Q4 earnings came out 2 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BNTC

CTXR

DYNT

MBIO

NRXP

SINT

SNOA

TRVN

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Shares of Alcoa Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aa#NYSE">AA</a>) rose sharply in today&rsquo;s pre-market trading after the company reported better-than-expected <a href="https://www.benzinga.com/quote/AA/earnings">sales for its first quarter</a>.
The company reported quarterly losses of 81 cents per share, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Alcoa still sees full-year alumina production of between 9.8 million and 10 million metric tons and full-year alumina shipments between 12.7 million and 12.9 million metric tons.
Alcoa shares jumped 3% to $36.60 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3>Gainers</h3>
<ul>
<li>Tian Ruixiang Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tirx#NASDAQ">TIRX</a>) shares gained 155.6% to $1.24 in pre-market trading after gaining around 8% on Wednesday.</li>
<li>MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) gained 51.8% to $3.40 in pre-market trading after falling around 5% on Wednesday.</li>
<li>Smart for Life, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smfl#NASDAQ">SMFL</a>) shares gained 28.4% to $0.6035 in pre-market trading after gaining over 21% on Wednesday.</li>
<li>Tantech Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tanh#NASDAQ">TANH</a>) gained 19.6% to $0.88 in pre-market trading.</li>
<li>Zapp Electric Vehicles Group Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zapp#NASDAQ">ZAPP</a>) shares rose 19.3% to $0.20 in pre-market trading after tumbling 35% on Wednesday.</li>
<li>ReTo Eco-Solutions Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reto#NASDAQ">RETO</a>) rose 19% to $1.13 in today&rsquo;s pre-market trading after tumbling 25% on Wednesday.</li>
<li>Acurx Pharmaceuticals Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acxp#NASDAQ">ACXP</a>) gained 10.6% to $1.99 in pre-market trading after gaining over 8% on Wednesday.</li>
<li>Bruush Oral Care Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brsh#NASDAQ">BRSH</a>) shares gained 10.4% to $0.0488 in pre-market trading.</li>
<li>Tenax Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tenx#NASDAQ">TENX</a>) shares gained 9.3% to $3.98 in pre-market trading.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>Planet Green Holdings Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/plag#NYSE">PLAG</a>) fell 20.6% to $0.16 in pre-market trading after dipping 10% on Wednesday.</li>
<li>Soligenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sngx#NASDAQ">SNGX</a>) fell 19.8% to $0.4090 in pre-market trading after gaining 8% on Wednesday.</li>
<li>NRx Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nrxp#NASDAQ">NRXP</a>) fell 19.4% to $3.36 in pre-market trading. NRx Pharmaceuticals announced a proposed underwritten public offering of common stock.</li>
<li>Semilux International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/selx#NASDAQ">SELX</a>) fell 17.8% to $1.29 in pre-market trading.</li>
<li>Trio Petroleum Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tpet#NASDAQ">TPET</a>) declined 17% to $0.2821 in pre-market trading. Trio Petroleum shares dipped 30% on Wednesday after the company announced it entered into a securities purchase agreement with an institutional investor in the amount of $360,000..</li>
<li>ICZOOM Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/izm#NASDAQ">IZM</a>) shares fell 15.6% to $5.05 in pre-market trading after tumbling 88% on Wednesday. ICZOOM announced cancellation of proposed public offering.</li>
<li>Arrowroot Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aile#NASDAQ">AILE</a>) fell 15% to $8.50 pre-market trading after dipping 42% on Wednesday.</li>
<li>SeaStar Medical Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icu#NASDAQ">ICU</a>) shares fell 14.2% to $0.60 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>Spectaire Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spec#NASDAQ">SPEC</a>) fell 13.3% to $0.6762 pre-market trading. Spectaire recently announced that it signed a distribution partnership agreement with a Fortune 1000 Energy Company.</li>
<li>Flora Growth Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flgc#NASDAQ">FLGC</a>) shares declined 10.5% to $1.60 in pre-market trading.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38307448/investor-sentiment-decreases-further-s-p-500-falls-for-fourth-straight-session"> Investor Sentiment Decreases Further, S&amp;P 500 Falls For Fourth Straight Session</a>

Penny Stocks

Small Cap

Trading Ideas

ACXP

AILE

BRSH

FLGC

PLAG

RETO

SELX

SMFL

TANH

TENX

ZAPP

Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Trevena (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVN#NASDAQ">TRVN</a>) shares increased by 27.0% to $0.51 during Wednesday's after-market session. The company's market cap stands at $9.2 million. </li>
<li>Mustang Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) stock increased by 11.97% to $0.43. The company's market cap stands at $4.4 million. </li>
<li>SINTX Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SINT#NASDAQ">SINT</a>) stock rose 10.32% to $0.04. The market value of their outstanding shares is at $5.0 million. </li>
<li>Fortress Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBIO#NASDAQ">FBIO</a>) stock moved upwards by 6.21% to $1.88. The market value of their outstanding shares is at $36.1 million. </li>
<li>TC BioPharm (Holdings) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBP#NASDAQ">TCBP</a>) stock increased by 5.92% to $1.43. The company's market cap stands at $4.5 million. </li>
<li>Acutus Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFIB#NASDAQ">AFIB</a>) shares moved upwards by 5.51% to $0.17. The company's market cap stands at $5.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>TRACON Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCON#NASDAQ">TCON</a>) shares decreased by 16.6% to $1.91 during Wednesday's after-market session. The market value of their outstanding shares is at $4.3 million. </li>
<li>DIH Holding US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DHAI#NASDAQ">DHAI</a>) stock fell 14.05% to $1.04. The market value of their outstanding shares is at $42.1 million. </li>
<li>Virax Biolabs Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAX#NASDAQ">VRAX</a>) shares fell 8.92% to $0.62. The company's market cap stands at $1.4 million. </li>
<li>Soligenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) shares declined by 7.85% to $0.47. The market value of their outstanding shares is at $4.9 million. </li>
<li>INVO Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVO#NASDAQ">INVO</a>) shares declined by 7.7% to $1.68. The market value of their outstanding shares is at $4.3 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>ProKidney (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROK#NASDAQ">PROK</a>) shares declined by 6.7% to $2.65. The company's market cap stands at $163.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AFIB

DHAI

FBIO

INVO

PROK

TCBP

TCON

VRAX

12 Health Care Stocks Moving In Wednesday's After-Market Session

By <a href="https://scr.zacks.com/analyst-bios/person-details/default.aspx?ItemId=e38a3af7-5620-44ff-b299-706e26bed702">David Bautz, PhD</a>
Business Update
Reaches Agreement with European Medicines Agency on Second Confirmatory Trial for HyBryte&trade;
On April 3, 2024, Soligenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sngx#NASDAQ">SNGX</a>) announced it has reached agreement with the European Medicines Agency (EMA) on the key design elements for a confirmatory Phase 3 trial of HyBryte (synthetic hypericin) for the treatment of cutaneous T cell lymphoma (CTCL).
The proposed Phase 3 FLASH 2 trial will be a randomized, double blind, placebo controlled, multicenter study that will enroll approximately 80 subjects with CTCL. HyBryte will be applied topically to CTCL lesions twice weekly for 18 weeks, with each application followed 21 (&plusmn; 3) hours later by the administration of visible light at a wavelength of 500 to 650 nm. The light will be administered starting at 6 J/cm2 and will be increased upwards by 2 J/cm2 until: 1) the patient experiences a Grade 1 erythema; 2) the patient reaches a maximum dose of 30 J/cm2, or 3) the patient cannot tolerate the treatment time, whichever comes first. All of the subject&#39;s lesions that are readily available to the visible light source will be treated and 3 to 5 index lesions will be prospectively identified and indexed for the modified composite assessment of index lesions severity (mCAILS) evaluation prior to randomization. The primary endpoint will be assessed by the percent of patients in each treatment group (HyBryte or placebo) achieving a Partial or Complete Response of the treated lesions defined as a &ge;50% reduction in the total mCAILS score for the 3-5 index lesions following 18 weeks of treatment compared to the total mCAILS score at baseline. Following treatment, subjects will be followed every 4 weeks for a total of 12 weeks (through Week 30). One interim analysis is planned after 60% of the total subjects have completed the primary endpoint evaluation. A sample size recalculation may be performed after examining the assumptions or the trial can be halted for futility, safety concerns, or overwhelming efficacy. The figure below gives a comparison between the proposed FLASH2 trial and the previously completed FLASH trial. The similarities between the two increases our confidence in a successful outcome for the FLASH2 trial.
<img src="//s27.q4cdn.com/906368049/files/pictures/2024/04112024_SNGX_1.png" style="width:650px" />
We anticipate that the trial will begin enrollment prior to the end of 2024 and topline results are expected in the second half of 2026. The company is continuing discussions with the U.S. Food and Drug Administration (FDA) on an appropriate study design as the agency has expressed a preference for a longer duration comparative study over a placebo-controlled trial.
Orphan Drug Designation for Sudan Ebolavirus Vaccine
On April 11, 2024, Soligenix announced that the U.S. FDA has granted orphan drug designation (ODD) to the active ingredient in SuVax&trade;, the subunit protein vaccine of recombinantly expressed Sudan ebolavirus (SUDV) glycoprotein, for &quot;the prevention and post-exposure prophylaxis against SUDV infection&quot;.
ODD is designed to assist companies that are developing therapies for rare diseases and disorders, defined as those that affect 200,000 people or fewer in the U.S. Drugs granted ODD receive a seven year term of market exclusivity upon final FDA approval. In addition, financial and regulatory benefits are available including government grants to conduct clinical trials, waiver of FDA user fees, and certain tax credits.
SuVax addresses the potentially lethal Sudan Virus Disease caused by SUDV. While vaccines exist for Zaire ebolavirus, they are ineffective against SUDV. Previous results showed that SuVax offered 100% protection of non-human primates infected with a lethal dose of SUDV. SuVax is based on the company&#39;s novel vaccine platform that consists of a robust protein manufacturing process, a nano-emulsion adjuvant that induces a strong immune response, and thermostabilization of the adjuvant and antigen in a single vial that is stable at elevated temperatures for extended timeframes.
Conclusion
We&#39;re glad to see that Soligenix is ready to move ahead with the second confirmatory Phase 3 clinical trial of HyBryte and we&#39;re confident that the FDA will come to an agreement with the company soon on its preferences for the trial. With a protocol in place for the second Phase 3 study of HyBryte we have increased our probability of approval, which has increased our valuation to $4.00.

Biotech

General

SNGX: Agreement with EMA on Second Confirmatory Trial for HyBryte™

Soligenix shares are trading higher after the company on Monday announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA.

U.S. stocks turned lower toward the end of trading, with the S&amp;P 500 falling more than 1% on Monday.
The Dow traded down 0.64% to 37,741.18 while the NASDAQ fell 1.68% to 15,902.96. The S&amp;P 500 also fell, dropping, 1.14% to 5,065.04.
Check This Out: <a href="https://www.benzinga.com/news/24/04/38218786/best-buy-box-and-2-other-stocks-insiders-are-selling"> Best Buy, Box And 2 Other Stocks Insiders Are Selling </a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Health care shares rose by 0.01% on Friday.
In trading on Friday, information technology shares fell by 1.8%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
U.S. retail sales increased 0.7% month-over-month in March following a revised 0.9% rise in February.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Soligenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sngx#NASDAQ">SNGX</a>) shares shot up 34% to $0.5197 after the company announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA.
Shares of Longeveron Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvn#NASDAQ">LGVN</a>) got a boost, surging 58% to $2.6750 following insider buys from multiple company executives.
Snap One Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snpo#NASDAQ">SNPO</a>) shares were also up, gaining 30% to $10.60 after the company announced that it will be acquired by Resideo Technologies.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Marinus Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrns#NASDAQ">MRNS</a>) shares dropped 81% to $1.4250 after the company provided an update on the Phase 3 RAISE trial and reported preliminary first-quarter financial results.
Shares of Neumora Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmra#NASDAQ">NMRA</a>) were down 11% to $12.02 after the FDA placed a clinical hold on the company&#39;s Phase 1 NMRA-266 study.
Ultragenyx Pharmaceutical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rare#NASDAQ">RARE</a>) was down, falling 10% to $42.73 after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Also Check This Out:<a href="https://www.benzinga.com/news/24/04/38246593/wall-streets-most-accurate-analysts-views-on-3-tech-stocks-with-over-4-dividend-yields"> Wall Street&#39;s Most Accurate Analysts&#39; Views On 3 Tech Stocks With Over 4% Dividend Yields </a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 0.6% to $85.17 while gold traded up 0.3% at $2,381.50.
Silver traded up 1.6% to $28.795 on Friday, while copper rose 2.3% to $4.3575.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares closed mostly higher today. The eurozone&rsquo;s STOXX 600 rose 0.13%, London&rsquo;s FTSE 100 fell 0.38% while Spain&rsquo;s IBEX 35 Index rose 0.01% The German DAX gained 0.54% French CAC 40 climbed 0.43% while Italy&rsquo;s FTSE MIB Index jumped 0.56%.
Industrial production in the eurozone increased by 0.8% month-over-month in February.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mostly lower on Monday, with Japan&rsquo;s Nikkei 225 falling 0.74%, Hong Kong&rsquo;s Hang Seng Index dropping 0.72%, China&rsquo;s Shanghai Composite gaining 1.26% and India&rsquo;s S&amp;P BSE Sensex dipping 1.14%.
Indian merchandise trade deficit shrank to $15.6 billion in March versus a year-ago gap of $18.1 billion, while wholesale prices rose by 0.53% year-over-year in March versus a 0.20% gain in the prior month.
&nbsp;
<h3>Economics</h3>
&nbsp;
The NY Empire State Manufacturing Index climbed to -14.3 in April versus prior month&rsquo;s reading of -20.9.
Retail sales increased 0.7% month-over-month in March following a revised 0.9% rise in February.
The NAHB/Wells Fargo Housing Market Index in came in unchanged at 51.0 in April.
Total business inventories increased by 0.4% month-over-month in February, versus market expectations of a 0.3% rise.
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38248683/bitcoin-surpasses-66-000-core-emerges-as-top-gainer"> Bitcoin Surpasses $66,000; Core Emerges As Top Gainer </a>
&nbsp;

Earnings

Eurozone

Commodities

Global

Intraday Update

LGVN

MRNS

NMRA

RARE

SNPO

S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rare#NASDAQ">RARE</a>) fell sharply during Monday&rsquo;s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Ultragenyx Pharmaceutical shares dipped 9.4% to $42.46 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Soligenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sngx#NASDAQ">SNGX</a>) shares surged 71.5% to $0.6679 after the company announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA.</li>
<li>Longeveron Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvn#NASDAQ">LGVN</a>) surged 54% to $2.6350 following insider buys from multiple company executives.</li>
<li>SuperCom Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spcb#NASDAQ">SPCB</a>) shares gained 39.4% to $0.3849 after jumping around 18% on Friday.</li>
<li>Piedmont Lithium Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pll#NYSE">PLL</a>) shares gained 32.1% to $16.75 following a 5% decline on Friday.</li>
<li>Snap One Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snpo#NASDAQ">SNPO</a>) surged 31.6% to $10.71 after the company announced that it will be acquired by Resideo Technologies.</li>
<li>Organovo Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onvo#NASDAQ">ONVO</a>) shares surged 30.9% to $1.32 after the company announced Phase 2 results for FXR314. Study results demonstrated statistically significant reduction in liver fat content from baseline in patients receiving FXR314 compared to placebo.</li>
<li>Kuke Music Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kuke#NASDAQ">KUKE</a>) jumped 27% to $2.7650.</li>
<li>HUB Cyber Security Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hubc#NASDAQ">HUBC</a>) gained 24% to $1.61 after gaining over 11% on Friday.</li>
<li>Edgio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egio#NASDAQ">EGIO</a>) gained 24% to $22.18.</li>
<li>Kaival Brands Innovations Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kavl#NASDAQ">KAVL</a>) surged 23.6% to $3.30.</li>
<li>Envoy Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coch#NASDAQ">COCH</a>) gained 22.6% to $6.19.</li>
<li>Medical Properties Trust, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mpw#NYSE">MPW</a>) rose 19.9% to $4.7850 after the company announced that it sold its majority interest in Utah Hospitals.</li>
<li>CareMax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmax#NASDAQ">CMAX</a>) climbed 19.5% to $3.78.</li>
<li>SES AI Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ses#NYSE">SES</a>) surged 18.7% to $1.77.</li>
<li>Mobile-health Network Solutions (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mndr#NASDAQ">MNDR</a>) gained 17.7% to $17.67.</li>
<li>Adial Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adil#NASDAQ">ADIL</a>) rose 16.7% to $2.72.</li>
<li>ProKidney Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prok#NASDAQ">PROK</a>) gained 16.7% to $2.0426.</li>
<li>Biotricity, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btcy#NASDAQ">BTCY</a>) rose 16.5% to $1.34.</li>
<li>Yatsen Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ysg#NYSE">YSG</a>) gained 13.3% to $3.41.</li>
<li>Destiny Tech100 Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dxyz#NASDAQ">DXYZ</a>) shares gained 12.8% to $32.71 after dipping 42% on Friday.</li>
<li>Encore Wire Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wire#NASDAQ">WIRE</a>) surged 11.7% to $291.60 after the company entered an agreement to be acquired by Prysmian for $290 per share in cash.</li>
<li>Century Aluminum Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cenx#NASDAQ">CENX</a>) gained 9.5% to $18.05.</li>
<li>Extreme Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/extr#NASDAQ">EXTR</a>) gained 5.7% to $11.31. B. Riley Securities analyst Dave Kang upgraded Extreme Networks from Neutral to Buy and maintained a $14 price target.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Marinus Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrns#NASDAQ">MRNS</a>) shares dipped 77% to $1.6800 after the company provided an update on the Phase 3 RAISE trial and reported preliminary Q1 financial results.</li>
<li>Swvl Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swvl#NASDAQ">SWVL</a>) fell 35% to $8.58.</li>
<li>VIA optronics AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/viao#NASDAQ">VIAO</a>) dipped 34% to $0.2765.</li>
<li>Veru Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/veru#NASDAQ">VERU</a>) fell 24% to $1.1550. Oppenheimer analyst Leland Gershell reiterated Veru with an Outperform and lowered the price target from $7 to $5.</li>
<li>Rent the Runway, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rent#NASDAQ">RENT</a>) dipped 19.8% to $15.42.</li>
<li>NextPlat Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxpl#NASDAQ">NXPL</a>) fell 19.8% to $1.50 after jumping 24% on Friday. The company entered into a definitive business combination agreement with its majority-owned subsidiary Progressive Care Inc.</li>
<li>Cyngn Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyn#NASDAQ">CYN</a>) shares fell 19.1% to $0.1170 after declining around 7% on Friday.</li>
<li>ProMIS Neurosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pmn#NASDAQ">PMN</a>) fell 15.6% to $1.95.</li>
<li>Biohaven Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bhvn#NASDAQ">BHVN</a>) dipped 15.4% to $44.90. Biohaven showcased innovative neuroscience portfolio with 20 presentations at the 2024 AAN Annual Meeting.</li>
<li>Neumora Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmra#NASDAQ">NMRA</a>) shares declined 15.1% to $11.48 after the FDA placed a clinical hold on the company&#39;s Phase 1 NMRA-266 study.</li>
<li>Alterity Therapeutics Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/athe#NASDAQ">ATHE</a>) dipped 15% to $2.49.</li>
<li>Surf Air Mobility Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srfm#NASDAQ">SRFM</a>) fell 15% to $0.53.</li>
<li>IM Cannabis Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imcc#NASDAQ">IMCC</a>) fell 14.2% to $0.5399.</li>
<li>Polestar Automotive Holding Uk Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/psny#NASDAQ">PSNY</a>) fell 12.7% to $1.2699. On Friday, Cantor Fitzgerald analyst Andres Sheppard reiterated Polestar Automotive with an Overweight and maintained a $5 price target.</li>
<li>Desktop Metal, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dm#NYSE">DM</a>) fell 10.8% to $0.8510.</li>
<li>Local Bounti Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/locl#NYSE">LOCL</a>) declined 10.2% to $2.1550.</li>
<li>Q32 Bio Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qttb#NASDAQ">QTTB</a>) fell 10% to $26.00.</li>
<li>SunPower Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spwr#NASDAQ">SPWR</a>) fell 8.3% to $2.2750.</li>
<li>Informatica Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/infa#NASDAQ">INFA</a>) dipped 8.1% to $35.36 amid increased volatility following reports suggesting Salesforce is in talks to buy the company.</li>
<li>TRACON Pharmaceuticals Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcon#NASDAQ">TCON</a>) declined 8.1% to $2.1699 after falling around 9% on Friday.</li>
<li>NOVONIX Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nvx#NYSE">NVX</a>) declined 7.2% to $2.63.</li>
<li>AudioEye, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aeye#NASDAQ">AEYE</a>) fell 6.6% to $12.86 after declining around 7% on Friday.</li>
<li>OncoCyte Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocx#NASDAQ">OCX</a>) fell 6.6% to $2.5301. Oncocyte announced a transplant assay partnership agreement with Bio-Rad laboratories.</li>
<li>BlackBerry Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bb#NYSE">BB</a>) fell 6.1% to $2.8650.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38249138/dow-jumps-over-300-points-goldman-sachs-posts-upbeat-earnings"> Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings</a>

ADIL

AEYE

Alterity Therapeutics Limited - American Depositary Shares

ATHE

BHVN

BTCY

CENX

CMAX

Envoy Medical, Inc. - Class A Common Stock

COCH

DXYZ

EGIO

EXTR

IMCC

INFA

KAVL

KUKE

LOCL

Nuveen California Dividend Advantage Municipal Fund 2

NXPL

ONVO

PSNY

QTTB

RENT

SPWR

SRFM

SWVL

VERU

VIAO

WIRE

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

On Monday,&nbsp;Soligenix Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) received an FDA orphan drug designation for the active ingredient in MarVax, the subunit protein vaccine of recombinantly expressed Marburg marburgvirus (MARV) glycoprotein, for the prevention and post-exposure prophylaxis&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/n38245390/fda-grants-soligenix-orphan-drug-designation-for-the-prevention-and-post-exposure-prophylaxis-agai" rel="noreferrer noopener">against MARV infection</a>.
In addition to providing a seven-year term of market exclusivity upon final FDA approval, orphan drug designation also positions Soligenix to be able to leverage a wide range of financial and regulatory benefits, including government grants for conducting clinical trials, waiver of expensive FDA user fees for the potential submission of a Biologics License Application (BLA), and certain tax credits.
Marburg marburgvirus causes Marburg Virus Disease, a highly related disease to the more commonly known Ebola Virus Disease.&nbsp;
Although MARV has caused fewer outbreaks, they remain highly fatal and a significant risk in continental Africa, with the most recent outbreak occurring in 2023. There is no approved vaccine for MARV, and the only approved vaccines for filovirus-type disease is specific to Zaire ebolavirus.
Just last week, the FDA granted Orphan Drug status to the active ingredient in Soligenix&#8217;s SuVax, the subunit protein vaccine of recombinantly expressed Sudan ebolavirus (SUDV) glycoprotein, for the prevention and post-exposure prophylaxis&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/n38199287/fda-grants-soligenix-orphan-drug-designation-for-the-prevention-and-post-exposure-prophylaxis-agai" rel="noreferrer noopener">against SUDV infection</a>.
Price Action:&nbsp;SNGX shares are up 37.2% at $0.53 on the last check Monday.

Health Care

Why Is Penny Stock Soligenix Trading Higher On Monday?

<h3>Gainers</h3>
<ul>
<li>Longeveron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) stock moved upwards by 44.4% to $2.44 during Monday's regular session. The market value of their outstanding shares is at $7.7 million. </li>
<li>Mobile-health Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDR#NASDAQ">MNDR</a>) shares rose 35.53% to $20.33. The company's market cap stands at $691.2 million. </li>
<li>Jaguar Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) shares moved upwards by 31.89% to $0.12. The company's market cap stands at $32.8 million. </li>
<li>Soligenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) stock increased by 30.35% to $0.5. The market value of their outstanding shares is at $5.2 million. </li>
<li>ProKidney (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROK#NASDAQ">PROK</a>) stock increased by 26.33% to $2.21. The company's market cap stands at $136.2 million. </li>
<li>Organovo Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONVO#NASDAQ">ONVO</a>) shares moved upwards by 24.58% to $1.26. The market value of their outstanding shares is at $12.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Marinus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNS#NASDAQ">MRNS</a>) shares fell 79.8% to $1.52 during Monday's regular session. The market value of their outstanding shares is at $83.4 million. </li>
<li>Alterity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHE#NASDAQ">ATHE</a>) stock decreased by 20.07% to $2.35. The company's market cap stands at $20.5 million. </li>
<li>BioSig Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) stock decreased by 18.76% to $1.1. The market value of their outstanding shares is at $10.3 million. </li>
<li>Rallybio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLYB#NASDAQ">RLYB</a>) shares fell 18.16% to $1.8. The market value of their outstanding shares is at $74.6 million. </li>
<li>MSP Recovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIFW#NASDAQ">LIFW</a>) stock fell 17.42% to $0.94. The market value of their outstanding shares is at $13.9 million. As per the news, the Q4 earnings report came out today. </li>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) stock declined by 17.15% to $1.16. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BSGM

JAGX

LIFW

RLYB

SXTC

12 Health Care Stocks Moving In Monday's Intraday Session

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Monday.
The Dow traded up 0.35% to 38,114.61 while the NASDAQ rose 0.07% to 16,187.02. The S&amp;P 500 also rose, gaining, 0.26% to 5,136.94.
Check This Out: <a href="https://www.benzinga.com/news/24/04/38218786/best-buy-box-and-2-other-stocks-insiders-are-selling"> Best Buy, Box And 2 Other Stocks Insiders Are Selling </a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Health care shares jumped by 0.7% on Friday.
In trading on Friday, real estate shares fell by 1.1%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Charles Schwab Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/schw#NYSE">SCHW</a>) reported better-than-expected first-quarter earnings on Monday.
Charles Schwab reported a first-quarter 2024 adjusted net income decline of 17% Y/Y to $1.469 billion. Adjusted EPS fell 20% Y/Y to 74 cents, which came in line with the consensus. Revenue fell 7% to $4.74 billion, marginally beating the consensus of $4.71 billion.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Soligenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sngx#NASDAQ">SNGX</a>) shares shot up 49% to $0.5802 after the company announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA.
Shares of Longeveron Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvn#NASDAQ">LGVN</a>) got a boost, surging 52% to $2.5650 following insider buys from multiple company executives.
Snap One Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snpo#NASDAQ">SNPO</a>) shares were also up, gaining 30% to $10.61 after the company announced that it will be acquired by Resideo Technologies.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Marinus Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrns#NASDAQ">MRNS</a>) shares dropped 79% to $1.5792 after the company provided an update on the Phase 3 RAISE trial and reported preliminary first-quarter financial results.
Shares of Neumora Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmra#NASDAQ">NMRA</a>) were down 14% to $11.67 after the FDA placed a clinical hold on the company&#39;s Phase 1 NMRA-266 study.
Ultragenyx Pharmaceutical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rare#NASDAQ">RARE</a>) was down, falling 10% to $42.46 after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Also Check This Out:<a href="https://www.benzinga.com/news/24/04/38246593/wall-streets-most-accurate-analysts-views-on-3-tech-stocks-with-over-4-dividend-yields"> Wall Street&#39;s Most Accurate Analysts&#39; Views On 3 Tech Stocks With Over 4% Dividend Yields </a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 1.3% to $84.55 while gold traded down 0.5% at $2,362.00.
Silver traded up 0.8% to $28.55 on Friday, while copper rose 1.7% to $4.3315.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were mostly higher today. The eurozone&rsquo;s STOXX 600 rose 0.06%, London&rsquo;s FTSE 100 fell 0.48% while Spain&rsquo;s IBEX 35 Index fell 0.11% The German DAX gained 0.39% French CAC 40 climbed 0.31% while Italy&rsquo;s FTSE MIB Index jumped 0.45%.
Industrial production in the eurozone increased by 0.8% month-over-month in February.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mostly lower on Monday, with Japan&rsquo;s Nikkei 225 falling 0.74%, Hong Kong&rsquo;s Hang Seng Index dropping 0.72%, China&rsquo;s Shanghai Composite gaining 1.26% and India&rsquo;s S&amp;P BSE Sensex dipping 1.14%.
Indian merchandise trade deficit shrank to $15.6 billion in March versus a year-ago gap of $18.1 billion, while wholesale prices rose by 0.53% year-over-year in March versus a 0.20% gain in the prior month.
&nbsp;
<h3>Economics</h3>
&nbsp;
The NY Empire State Manufacturing Index climbed to -14.3 in April versus prior month&rsquo;s reading of -20.9.
Retail sales increased 0.7% month-over-month in March following a revised 0.9% rise in February.
The NAHB/Wells Fargo Housing Market Index in came in unchanged at 51.0 in April.
Total business inventories increased by 0.4% month-over-month in February, versus market expectations of a 0.3% rise.
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38248683/bitcoin-surpasses-66-000-core-emerges-as-top-gainer"> Bitcoin Surpasses $66,000; Core Emerges As Top Gainer </a>

SCHW

Crude Oil Down 1%; Charles Schwab Sales Top Estimates

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Monday.
The Dow traded up 0.89% to 38,321.05 while the NASDAQ rose 0.70% to 16,288.03. The S&amp;P 500 also rose, gaining, 0.80% to 5,164.30.
Check This Out: <a href="https://www.benzinga.com/news/24/04/38218786/best-buy-box-and-2-other-stocks-insiders-are-selling"> Best Buy, Box And 2 Other Stocks Insiders Are Selling </a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Financial shares jumped by 1.5% on Friday.
In trading on Friday, real estate shares rose by just 0.3%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Goldman Sachs Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gs#NYSE">GS</a>) reported better-than-expected first-quarter earnings on Monday.
Goldman Sachs reported revenue of $14.21 billion for the first quarter of 2024, beating the consensus of $12.92 billion. The U.S. financial services giant reported EPS of $11.58, beating the consensus of $8.60.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Soligenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sngx#NASDAQ">SNGX</a>) shares shot up 98% to $0.7699 after the company announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA.
Shares of Longeveron Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvn#NASDAQ">LGVN</a>) got a boost, surging 70% to $2.87 following insider buys from multiple company executives.
Organovo Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onvo#NASDAQ">ONVO</a>) shares were also up, gaining 23% to $1.2613 after the company announced Phase 2 results for FXR314. Study results demonstrated statistically significant reduction in liver fat content from baseline in patients receiving FXR314 compared to placebo.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Marinus Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrns#NASDAQ">MRNS</a>) shares dropped 76% to $1.7680 after the company provided an update on the Phase 3 RAISE trial and reported preliminary Q1 financial results.
Shares of ProMIS Neurosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pmn#NASDAQ">PMN</a>) were down 29% to $1.63.
PaxMedica, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pxmd#NASDAQ">PXMD</a>) was down, falling 23% to $0.6501. PaxMedica, last week, announced the completed execution of three pivotal registration/validation batches of PAX-101.
Also Check This Out:<a href="https://www.benzinga.com/news/24/04/38246593/wall-streets-most-accurate-analysts-views-on-3-tech-stocks-with-over-4-dividend-yields"> Wall Street&#39;s Most Accurate Analysts&#39; Views On 3 Tech Stocks With Over 4% Dividend Yields </a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded up 0.5% to $85.43 while gold traded down 0.8% at $2,353.50.
Silver traded down 0.6% to $28.075 on Friday, while copper rose 0.1% to $4.2580.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were higher today. The eurozone&rsquo;s STOXX 600 rose 0.8%, London&rsquo;s FTSE 100 gained 0.1% while Spain&rsquo;s IBEX 35 Index rose 0.6% The German DAX gained 1.4% French CAC 40 climbed 1.3% while Italy&rsquo;s FTSE MIB Index jumped 1.5%.
Industrial production in the eurozone increased by 0.8% month-over-month in February.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mostly lower on Monday, with Japan&rsquo;s Nikkei 225 falling 0.74%, Hong Kong&rsquo;s Hang Seng Index dropping 0.72%, China&rsquo;s Shanghai Composite gaining 1.26% and India&rsquo;s S&amp;P BSE Sensex dipping 1.14%.
Indian merchandise trade deficit shrank to $15.6 billion in March versus a year-ago gap of $18.1 billion, while wholesale prices rose by 0.53% year-over-year in March versus a 0.20% gain in the prior month.
&nbsp;
<h3>Economics</h3>
&nbsp;
The NY Empire State Manufacturing Index climbed to -14.3 in April versus prior month&rsquo;s reading of -20.9.
Retail sales increased 0.7% month-over-month in March following a revised 0.9% rise in February.
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38248683/bitcoin-surpasses-66-000-core-emerges-as-top-gainer"> Bitcoin Surpasses $66,000; Core Emerges As Top Gainer </a>

PXMD

Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings

<h3>Gainers</h3>
<ul>
<li>Soligenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) stock increased by 95.1% to $0.75 during Monday's pre-market session. The company's market cap stands at $7.9 million. </li>
<li>Longeveron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) shares increased by 51.47% to $2.56. The company's market cap stands at $8.1 million. </li>
<li>Cartesian Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAC#NASDAQ">RNAC</a>) shares moved upwards by 40.02% to $27.15. The company's market cap stands at $482.7 million. </li>
<li>Biomerica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRA#NASDAQ">BMRA</a>) shares rose 21.98% to $1.01. The company's market cap stands at $16.9 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>Allarity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLR#NASDAQ">ALLR</a>) shares increased by 21.42% to $2.55. The company's market cap stands at $1.2 million. </li>
<li>Envoy Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCH#NASDAQ">COCH</a>) stock moved upwards by 18.81% to $6.0. The company's market cap stands at $117.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Marinus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNS#NASDAQ">MRNS</a>) stock decreased by 74.5% to $1.92 during Monday's pre-market session. The market value of their outstanding shares is at $105.4 million. </li>
<li>TRACON Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCON#NASDAQ">TCON</a>) shares decreased by 17.8% to $1.94. The market value of their outstanding shares is at $4.4 million. </li>
<li>Neumora Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRA#NASDAQ">NMRA</a>) shares declined by 17.04% to $11.25. The company's market cap stands at $1.7 billion. </li>
<li>PaxMedica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PXMD#NASDAQ">PXMD</a>) stock fell 16.57% to $0.7. The market value of their outstanding shares is at $5.1 million. </li>
<li>Alterity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHE#NASDAQ">ATHE</a>) stock fell 15.65% to $2.48. The market value of their outstanding shares is at $21.6 million. </li>
<li>SINTX Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SINT#NASDAQ">SINT</a>) shares decreased by 15.19% to $0.02. The market value of their outstanding shares is at $2.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALLR

BMRA

RNAC

12 Health Care Stocks Moving In Monday's Pre-Market Session

Soligenix shares are trading higher after the company announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA.

FDA Grants Soligenix Orphan Drug Designation To Active Ingredient In MarVax For Prevention And Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection

Soligenix Receives FDA Orphan Drug Designation For The Active Ingredient In SuVax, The Subunit Protein Vaccine Of Recombinantly Expressed Sudan Ebolavirus (SUDV) Glycoprotein, For The Prevention And Post-Exposure Prophylaxis Against SUDV Infection

Shares of Biophytis S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bpts#NASDAQ">BPTS</a>) rose sharply in today&rsquo;s pre-market trading after <a href="https://www.benzinga.com/quote/BPTS/earnings">reporting FY23 results</a>.
Biophytis posted a FY23 loss of &euro;0.03 per share, versus a year-ago loss of &euro;0.14 per share, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Biophytis shares jumped 55.2% to $0.4920 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3>Gainers</h3>
<ul>
<li>MyMD Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mymd#NASDAQ">MYMD</a>) shares rose 40% to $3.64 in pre-market trading after jumping 22% on Monday.</li>
<li>MediaCo Holding Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdia#NASDAQ">MDIA</a>) shares rose 20.2% to $3.63 in pre-market trading after falling 22% on Monday. On April 4, an SEC filing showed Standard General L.P. reported a 95.2% stake in the company, as of April 1.</li>
<li>Destiny Tech100 Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dxyz#NASDAQ">DXYZ</a>) gained 18.5% to $118.33 in pre-market trading after jumping over 68% on Monday.</li>
<li>Addex Therapeutics Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adxn#NASDAQ">ADXN</a>) shares gained 17.2% to $25.60 in pre-market trading after jumping around 21% on Monday. Addex Therapeutics and funds affiliated with Perceptive Advisors, last week, announced the launch of Neurosterix.</li>
<li>Anghami Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/angh#NASDAQ">ANGH</a>) gained 16.1% to $1.30 in pre-market trading after dipping over 3% on Monday.</li>
<li>Brainstorm Cell Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcli#NASDAQ">BCLI</a>) climbed 15% to $0.8395 in pre-market trading after jumping around 12% on Monday. The company, last week, reported FY23 financial results.</li>
<li>Soligenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sngx#NASDAQ">SNGX</a>) shares gained 12.5% to $0.54 in pre-market trading after adding around 3% on Monday.</li>
<li>TuanChe Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tc#NASDAQ">TC</a>) rose 10.8% to $2.16 in pre-market trading.</li>
<li>Halozyme Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/halo#NASDAQ">HALO</a>) gained 10.7% to $2.16 in pre-market trading after declining around 3% on Monday.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>Vincerx Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vinc#NASDAQ">VINC</a>) declined 52.1% to $2.29 in pre-market trading after the company presented preliminary Phase 1 data for VIP236 and updates on pipeline progress at the AACR Annual Meeting 2024.</li>
<li>Focus Universal Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fcuv#NASDAQ">FCUV</a>) fell 30.8% to $0.2424 in pre-market trading. Focus Universal, on Monday, announced Warren Wang as Chief Strategy Officer.</li>
<li>UTime Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wto#NASDAQ">WTO</a>) fell 26.1% to $0.2216 in pre-market trading. UTime shares jumped 62% on Monday after the company completed a private placement.</li>
<li>BioSig Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bsgm#NASDAQ">BSGM</a>) fell 22.8% to $0.9570 in pre-market trading after jumping over 96% on Monday.</li>
<li>Guardion Health Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ghsi#NASDAQ">GHSI</a>) shares declined 20.8% to $7.05 in pre-market trading.</li>
<li>Maxeon Solar Technologies, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/maxn#NASDAQ">MAXN</a>) fell 16.8% to $2.27 pre-market trading. Maxeon Solar said it sees preliminary fourth-quarter revenue of $229 million versus market estimates of $235.959 million.</li>
<li>Hanryu Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hryu#NASDAQ">HRYU</a>) shares fell 15.8% to $0.24 in pre-market trading after jumping over 31% on Monday.</li>
<li>VBI Vaccines Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vbiv#NASDAQ">VBIV</a>) fell 12.4% to $0.8037 in pre-market trading after jumping around 30% on Monday.</li>
<li>Eco Wave Power Global AB (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wave#NASDAQ">WAVE</a>) shares fell 11.2% to $3.73 in pre-market trading. Eco Wave. Power global shares jumped 219% on Monday after the company announced that it was selected by an international energy company to conduct wave energy feasibility studies for the U.S. coastline.</li>
<li>DigiAsia Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/faas#NASDAQ">FAAS</a>) fell 9.9% to $7.00 pre-market trading after surging over 20% on Monday.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38154597/neogen-maxeon-solar-technologies-and-3-stocks-to-watch-heading-into-tuesday"> Neogen, Maxeon Solar Technologies And 3 Stocks To Watch Heading Into Tuesday</a>

ADXN

ANGH

BCLI

BPTS

FAAS

FCUV

GHSI

HALO

HRYU

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MDIA

MyMD Pharmaceuticals, Inc. - Common Stock

MYMD

VBIV

VINC

WAVE

Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Friday is here and we&rsquo;re starting the final day of trading this week with a breakdown of the biggest pre-market stock movers this morning!



Moving stocks this morning are earnings reports, stakeholder updates, drug development news and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>PaxMedica (NASDAQ:<a href="https://investorplace.com/stock-quotes/pxmd-stock-quote/">PXMD</a>) stock is rocketing close to 82% after hitting a <a href="https://www.nasdaq.com/press-release/paxmedica-achieves-key-milestone-in-the-development-of-pax-101-and-provides-update-on">key milestone in drug development</a>.</li>



<li>Allarity Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/allr-stock-quote/">ALLR</a>) shares are soaring more than 61% alongside heavy pre-market trading.</li>



<li>Zapata Computing (NASDAQ:<a href="https://investorplace.com/stock-quotes/zpta-stock-quote/">ZPTA</a>) stock is surging over 36% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318230226&amp;type=PDF&amp;symbol=ZPTA&amp;cdn=e948601bd73c48c35f25d9d7dd224e92&amp;companyName=Zapata+Computing+Holdings+Inc.&amp;formType=SC+13G%2FA&amp;formDescription=%5BAmend%5D+Statement+of+acquisition+of+beneficial+ownership+by+individuals&amp;dateFiled=2024-04-11">following a stakeholder update</a>.</li>



<li>NextPlat (NASDAQ:<a href="https://investorplace.com/stock-quotes/nxpl-stock-quote/">NXPL</a>) shares are rising 32% alongside a <a href="https://www.nasdaq.com/press-release/nextplat-reports-consolidated-year-end-2023-results-with-increased-revenues-of-%2437.8">positive 2023 earnings report</a>.</li>



<li>AMTD Digital (NYSE:<a href="https://investorplace.com/stock-quotes/hkd-stock-quote/">HKD</a>) stock is increasing more than 25% with strong early morning trading.</li>



<li>Beneficient (NASDAQ:<a href="https://investorplace.com/stock-quotes/benf-stock-quote/">BENF</a>) shares are gaining over 25% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318230412&amp;type=PDF&amp;symbol=BENF&amp;cdn=eb254668ceab70d3f25ad97304b464e9&amp;companyName=Beneficient&amp;formType=SC+13D%2FA&amp;formDescription=%5BAmend%5D+General+statement+of+acquisition+of+beneficial+ownership&amp;dateFiled=2024-04-11">a stakeholder update</a>.</li>



<li>NRX Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/nrxp-stock-quote/">NRXP</a>) stock is heading more than 18% higher <a href="https://www.nasdaq.com/press-release/nrxs-nasdaq%3a-nrxp-nmda-modification-therapy-and-its-multiple-applications-from-mental">on therapy news</a>.</li>



<li>Lyell Immunopharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/lyel-stock-quote/">LYEL</a>) shares are jumping over 15% this morning.</li>



<li>Soligenix (NASDAQ:<a href="https://investorplace.com/stock-quotes/sngx-stock-quote/">SNGX</a>) stock is climbing more than 14% on <a href="https://www.nasdaq.com/press-release/fda-grants-soligenix-orphan-drug-designation-for-the-prevention-and-post-exposure">positive drug news</a>.</li>



<li>OncoCyte (NASDAQ:<a href="https://investorplace.com/stock-quotes/ocx-stock-quote/">OCX</a>) shares are up over 14% with its <a href="https://ng.investing.com/news/stock-market-news/oncocyte-reports-full-year-2023-financial-results-93CH-1298708">Q4 earnings report</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Motus GI (NASDAQ:<a href="https://investorplace.com/stock-quotes/mots-stock-quote/">MOTS</a>) stock is plummeting more than 35% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318230488&amp;type=PDF&amp;symbol=MOTS&amp;cdn=84b00af3974179838345280e52876622&amp;companyName=Motus+GI+Holdings+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-11">on a delisting warning</a>.</li>



<li>Spectaire (NASDAQ:<a href="https://investorplace.com/stock-quotes/spec-stock-quote/">SPEC</a>) shares are diving 17% despite a lack of news today.</li>



<li>Rent the Runway (NASDAQ:<a href="https://investorplace.com/stock-quotes/rent-stock-quote/">RENT</a>) stock is retreating over 15% <a href="https://investorplace.com/2024/04/why-is-rent-the-runway-rent-stock-up-30-today/">after rallying yesterday</a>.</li>



<li>Monogram Orthopaedics (NASDAQ:<a href="https://investorplace.com/stock-quotes/mgrm-stock-quote/">MGRM</a>) shares are tumbling more than 13% as it <a href="https://www.nasdaq.com/press-release/monogram-accepted-to-nvidia-inception-program-2024-04-11">also jumped higher yesterday</a>.</li>



<li>Rallybio (NASDAQ:<a href="https://investorplace.com/stock-quotes/rlyb-stock-quote/">RLYB</a>) stock is pulling back over 11% after a <a href="https://investorplace.com/2024/04/why-is-rallybio-rlyb-stock-up-93-today/">major rally on Thursday</a>.</li>



<li>Applied Digital (NASDAQ:<a href="https://investorplace.com/stock-quotes/apld-stock-quote/">APLD</a>) shares are falling more than 11% with its <a href="https://finance.yahoo.com/news/applied-digital-reports-fiscal-third-200500599.html">fiscal Q3 2024 earnings report</a>.</li>



<li>Kazia Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/kzia-stock-quote/">KZIA</a>) stock is taking an over 10% beating without any clear news this morning.</li>



<li>MOGU (NYSE:<a href="https://investorplace.com/stock-quotes/mogu-stock-quote/">MOGU</a>) shares are decreasing more than 10% with no obvious news to report.</li>



<li>Marin Software (NASDAQ:<a href="https://investorplace.com/stock-quotes/mrin-stock-quote/">MRIN</a>) stock is dropping over 10% <a href="https://investorplace.com/2024/04/why-is-marin-software-mrin-stock-up-62-today/">after rallying recently</a>.</li>



<li>GCT Semiconductor (NYSE:<a href="https://investorplace.com/stock-quotes/gcts-stock-quote/">GCTS</a>) shares close out our pre-market stock movers down more than 10%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-april-12th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Soligenix stock soars 106% on FDA orphan drug status

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Soligenix (NASDAQ:<a href="https://investorplace.com/stock-quotes/sngx-stock-quote/">SNGX</a>) stock is rocketing higher on Monday after getting an <a href="https://finance.yahoo.com/news/fda-grants-soligenix-orphan-drug-113000333.html">orphan drug designation</a> for the active ingredient in MarVax.



This comes from the Food and Drug Administration&rsquo;s (FDA) Office of Orphan Products Development. This specifically covers &ldquo;the prevention and post-exposure prophylaxis against MARV infection.&rdquo;



Christopher J. Schaber, PhD, president and CEO of Soligenix, said the following about the news.




&ldquo;Although MARV has caused fewer outbreaks, they remain highly fatal and a significant risk in continental Africa, with the most recent outbreak occurring in 2023. There is no approved vaccine for MARV, and the only approved vaccines for filovirus type disease is specific to Zaire ebolavirus.&rdquo;




<h2>What This Means for SNGX Stock</h2>



This designation helps Soligenix with its use of MarVax as a preventer of MARV infection. That includes additional support from the FDA during its development in the form of financial and regulatory benefits.



This positive news brings with it extra trading activity for SNGX stock today. That has more than 115 million shares changing hands as of this writing. For the record, the company&rsquo;s daily average trading volume is about 165,000 shares.



SNGX stock is up 58% as of Monday morning.



Investors will find more of the most recent stock market stories ready to go below!



We have all of the hottest stock market news traders need to know about on Monday! A few examples include what&rsquo;s happening with shares of Hawaiian Electric&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/he-stock-quote/">HE</a>), Salesforce&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/crm-stock-quote/">CRM</a>) and Piedmont Lithium&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/pll-stock-quote/">PLL</a>) stock. ALl of this info is ready to go at the following links!



<h2>More Stock Market News for Monday</h2>



<ul><li><a href="https://investorplace.com/2024/04/hawaiian-electric-power-outages-what-to-know-about-widespread-oahu-outages/">Hawaiian Electric Power Outages: What to Know About Widespread O&rsquo;ahu Outages</a></li>



<li><a href="https://investorplace.com/2024/04/crm-stock-alert-why-salesforce-wants-to-buy-informatica/">CRM Stock Alert: Why Salesforce Wants to Buy Informatica</a></li>



<li><a href="https://investorplace.com/2024/04/pll-stock-alert-piedmont-lithium-surges-on-north-carolina-mine-permit/">PLL Stock Alert: Piedmont Lithium Surges on North Carolina Mine Permit</a></li>
</ul>On <a href="https://investorplace.com/stock-types/penny-stocks/">Penny Stocks</a> and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/why-is-soligenix-sngx-stock-up-58-today/">Why Is Soligenix (SNGX) Stock Up 58% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Soligenix (SNGX) Stock Up 58% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Marinus Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/mrns-stock-quote/">MRNS</a>) stock is taking a beating on Monday after the pharmaceutical company announced results from a Phase 3 clinical trial.



It&rsquo;s bad news for MRNS stockholders today as the Phase 3 trail of intravenous ganaxolone as a treatment for refractory status epilepticus (RSE) <a href="https://finance.yahoo.com/news/marinus-pharmaceuticals-provides-phase-3-110000137.html">failed to meet expectations</a>. The company was hoping for the drug to meet the criteria for early stopping of the trial.



Without that, the company won&rsquo;t have the final results from the Phase 3 trial until the summer. The company also remains blind to the data and is continuing the trial at the recommendation of an independent Data Monitoring Committee.



Marinus Pharmaceuticals chairman and CEO Scott Braunstein said this about the news.




&ldquo;While we are disappointed that RAISE did not meet the early stopping criteria, we will only be able to determine the trial&rsquo;s outcome once we unblind and analyze the full data set. We will also be evaluating potential cost-saving strategies to provide the strongest capital position as we approach enrollment completion in the global Phase 3 TrustTSC trial in tuberous sclerosis complex.&rdquo;




<h2>How This Affects MRNS Stock Today</h2>



With this news comes heavy trading of MRNS stock as investors sell their shares. That has more than 13 million units traded as of this writing. This is higher than its daily average trading volume of about 443,000 shares.



MRNS stock is down 78.9% as of Monday morning.



Investors will find more of the most recent stock market stories ready to go below!



We are offering insight into all of the hottest stock market news for Monday! That includes everything happening with shares of Soligenix&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/sngx-stock-quote/">SNGX</a>), Hawaiian Electric&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/he-stock-quote/">HE</a>) and Salesforce&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/crm-stock-quote/">CRM</a>) stock today. You can catch up on these matters at the following links!



<h2>More Monday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/04/why-is-soligenix-sngx-stock-up-58-today/">Why Is Soligenix (SNGX) Stock Up 58% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/hawaiian-electric-power-outages-what-to-know-about-widespread-oahu-outages/">Hawaiian Electric Power Outages: What to Know About Widespread O&rsquo;ahu Outages</a></li>



<li><a href="https://investorplace.com/2024/04/crm-stock-alert-why-salesforce-wants-to-buy-informatica/">CRM Stock Alert: Why Salesforce Wants to Buy Informatica</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/why-is-marinus-pharmaceuticals-mrns-stock-down-79-today/">Why Is Marinus Pharmaceuticals (MRNS) Stock Down 79% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Marinus Pharmaceuticals (MRNS) Stock Down 79% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Trump Media &amp; Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/djt-stock-quote/">DJT</a>) stock is falling on Monday after the Truth Social operator filed with the Securities and Exchange Commission (SEC) for a share sale.



Trump Media <a href="https://finance.yahoo.com/news/trump-media-technology-group-files-131700561.html">filed a Form S-1</a> with the SEC for the potential resale of shares by current stockholders. The company notes that this comes after it went public via a special purpose acquisition company (SPAC) merger with Digital World Acquisition on March 25.



According to its press release, Trump Media &amp; Technology points out that it won&rsquo;t see any funds from this share sale. That&rsquo;s due to the stock in this sale already being owned by shareholders in the company. However, it may see funds if connected warrants are exercised.



<h2>How This Affects DJT Stock</h2>



When a secondary shareholder offer like this is announced it often brings a drop to a company&rsquo;s stock. That&rsquo;s partially due to it lowering investor morale as a major investor lowers its stake in the company.



Another worry for traders is the affect this sale could have on the price of DJT stock. If the holder chooses to sell these shares for a discount, that could further pull down the price of the company&rsquo;s stock. 



DJT stock is down 14.4% as of Monday morning with more than 4.4 million shares traded. That&rsquo;s still below its daily average trading volume of about 6.6 million shares.



Investors looking for more of the most recent stock market stories will want to stick around!



We have all of the hottest stock market news ready to go on Monday! Among that is what has shares of Marinus Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mrns-stock-quote/">MRNS</a>), Soligenix&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/sngx-stock-quote/">SNGX</a>) and Hawaiian Electric&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/he-stock-quote/">HE</a>) stock moving today. All of that news is ready to go down below!



<h2>More Stock Market News for Monday</h2>



<ul><li><a href="https://investorplace.com/2024/04/why-is-marinus-pharmaceuticals-mrns-stock-down-79-today/">Why Is Marinus Pharmaceuticals (MRNS) Stock Down 79% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-soligenix-sngx-stock-up-58-today/">Why Is Soligenix (SNGX) Stock Up 58% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/hawaiian-electric-power-outages-what-to-know-about-widespread-oahu-outages/">Hawaiian Electric Power Outages: What to Know About Widespread O&rsquo;ahu Outages</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/djt-stock-alert-trump-media-plunges-on-share-sale-panic/">DJT Stock Alert: Trump Media Plunges on Share Sale Panic</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

DJT Stock Alert: Trump Media Plunges on Share Sale Panic

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Stocks are up today and investors wondering what&rsquo;s behind that rally have come to the right place as we have the latest news for Monday!



Stocks are up today as <a href="https://finance.yahoo.com/news/retail-sales-topped-wall-street-estimates-in-march-124009661.html">retail data came in better than expected</a>. The data saw retail sales in March increase by .7%, as compared to the .4% increase that Wall Street was expecting.



To go along with that, the retail sales data for February was revised in the latest report. This bumped it up to a .9% increase from the previous report of a .6% increase.



In addition to that is a strong earnings report from Goldman Sachs (NYSE:<a href="https://investorplace.com/stock-quotes/gs-stock-quote/">GS</a>). The financial firm saw its profits rise higher during its most recent quarter. This has net income for the period <a href="https://finance.yahoo.com/news/profits-surge-at-goldman-sachs-on-wall-street-revival-112940260.html">sitting at $4.1 billion</a>.



Let&rsquo;s check out how all of this news is affecting <a href="https://finance.yahoo.com/world-indices/">the major indices</a> below!



<h2>Stocks Up Today: Major Indices Rally</h2>



<ul><li>The S&amp;P 500 starts us off with a .31% increase as of noon Monday.</li>



<li>Next we have the Dow Jones Industrial Average with a .39% rise as of this writing.</li>



<li>Closing us out is the NASDAQ Composite with a .1% gain today.</li>
</ul>Investors who are seeking out even more of the most recent stock market stories are going to want to stick around!



We are offering up all of the hottest stock market news that traders need to know about on Monday! A few examples include what&rsquo;s going on with shares of Trump Media &amp; Technology&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/djt-stock-quote/">DJT</a>), Marinus Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mrns-stock-quote/">MRNS</a>) and Soligenix&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/sngx-stock-quote/">SNGX</a>) stock today. All of that info is ready to go at the links below!



<h2>More Monday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/04/djt-stock-alert-trump-media-plunges-on-share-sale-panic/">DJT Stock Alert: Trump Media Plunges on Share Sale Panic</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-marinus-pharmaceuticals-mrns-stock-down-79-today/">Why Is Marinus Pharmaceuticals (MRNS) Stock Down 79% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-soligenix-sngx-stock-up-58-today/">Why Is Soligenix (SNGX) Stock Up 58% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/why-are-stocks-up-today-april-15th/">Why Are Stocks Up Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Are Stocks Up Today?

BSGM, ENLV and WISA among mid-day movers

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Thursday morning!



Moving stocks this morning are earnings reports, shareholder meetings, public offerings and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Tian Ruixiang (NASDAQ:<a href="https://investorplace.com/stock-quotes/tirx-stock-quote/">TIRX</a>) stock is rocketing more than 151% after announcing plans for an <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318240834&amp;type=PDF&amp;symbol=TIRX&amp;cdn=28383035430ee99a000270a0a49b5cf7&amp;companyName=TIAN+RUIXIANG+Holdings+Ltd&amp;formType=6-K&amp;formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&amp;dateFiled=2024-04-17">extraordinary general shareholders meeting</a>.</li>



<li>MicroCloud Hologram (NASDAQ:<a href="https://investorplace.com/stock-quotes/holo-stock-quote/">HOLO</a>) shares are soaring over 52% alongside heavy pre-market trading.</li>



<li>Secoo (NASDAQ:<a href="https://investorplace.com/stock-quotes/seco-stock-quote/">SECO</a>) stock is surging more than 32% with strong early morning trading.</li>



<li>Smart for Life (NASDAQ:<a href="https://investorplace.com/stock-quotes/smfl-stock-quote/">SMFL</a>) shares are rising over 23% after announcing it will <a href="https://www.nasdaq.com/press-release/smart-for-life-to-sponsor-industry-event-whats-up-with-supps-at-supplyside-east-2024">sponsor an upcoming event</a>.</li>



<li>Tenax Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/tenx-stock-quote/">TENX</a>) stock is gaining 17% on Thursday morning.</li>



<li>Earlyworks (NASDAQ:<a href="https://investorplace.com/stock-quotes/elws-stock-quote/">ELWS</a>) shares are increasing more than 16% despite a lack of news this morning.</li>



<li>Citius Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/ctxr-stock-quote/">CTXR</a>) stock is climbing over 16% without any apparent news on Thursday.</li>



<li>ReTo Eco-Solutions (NASDAQ:<a href="https://investorplace.com/stock-quotes/reto-stock-quote/">RETO</a>) shares are heading more than 15% higher this morning.</li>



<li>CERo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cero-stock-quote/">CERO</a>) stock is jumping over 14% with no obvious news to report.</li>



<li>Bruush Oral Care (NASDAQ:<a href="https://investorplace.com/stock-quotes/brsh-stock-quote/">BRSH</a>) shares are up more than 13% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Semilux International (NASDAQ:<a href="https://investorplace.com/stock-quotes/selx-stock-quote/">SELX</a>) stock is crashing over 43% with no obvious news this morning.</li>



<li>Canaan (NASDAQ:<a href="https://investorplace.com/stock-quotes/can-stock-quote/">CAN</a>) shares are plummeting more than 28% after releasing its <a href="https://www.nasdaq.com/press-release/canaan-inc.-files-2023-annual-report-on-form-20-f-2024-04-17">2023 annual report</a>.</li>



<li>NRX Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/nrxp-stock-quote/">NRXP</a>) stock is diving over 24% on a <a href="https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-announces-proposed-underwritten-public-offering-of-common-stock-302120123.html">proposed public offering</a>.</li>



<li>Trilogy Metals (NYSEMKT:<a href="https://investorplace.com/stock-quotes/tmq-stock-quote/">TMQ</a>) shares are tumbling more than 22% on an <a href="https://investorplace.com/2024/04/why-is-trilogy-metals-tmq-stock-down-29-today/">Ambler Access Project update</a>.</li>



<li>Lithium Americas (NYSE:<a href="https://investorplace.com/stock-quotes/laac-stock-quote/">LAAC</a>) stock is taking an over 20% beating on <a href="https://seekingalpha.com/news/4090749-lithium-americas-sinks-on-plans-for-55m-share-offering?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain">plans for a share offering</a>.</li>



<li>Soligenix (NASDAQ:<a href="https://investorplace.com/stock-quotes/sngx-stock-quote/">SNGX</a>) shares are falling more than 20% <a href="https://investorplace.com/2024/04/why-is-soligenix-sngx-stock-up-58-today/">following a recent rally</a>.</li>



<li>Reliance Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/reli-stock-quote/">RELI</a>) stock is dropping over 19% on Thursday morning.</li>



<li>Trio Petroleum (NYSEMKT:<a href="https://investorplace.com/stock-quotes/tpet-stock-quote/">TPET</a>) shares are decreasing close to 17% as it <a href="https://investorplace.com/2024/04/why-is-trio-petroleum-tpet-stock-down-22-today/">continues recent negative movement</a>.</li>



<li>iLearningEngines (NASDAQ:<a href="https://investorplace.com/stock-quotes/aile-stock-quote/">AILE</a>) stock is declining 15% today.</li>



<li>SeaStar Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/icu-stock-quote/">ICU</a>) shares close out our pre-market stock movers down more than 14% with the release of its <a href="https://www.nasdaq.com/press-release/seastar-medical-reports-2023-financial-results-and-provides-a-business-update-2024-04">2023 financial results</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-april-18th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Soligenix stock dips on pricing $5.0 million securities offering

Soligenix stock dips on pricing $4.75 million securities offering

APLD

BENF

CERO

CISS

ELWS

ENLV

GCTS

KZIA

LAAC

LYEL

MGRM